Abstract:The glutamate transporter GLT‐1 is predominantly expressed in astrocytes. In neurons, GLT‐1 is expressed mainly in axon terminals. Conditional knockout of the gene expressing GLT‐1 in neurons prevents recovery of hippocampal synaptic function by increased vulnerability to excitotoxic injury. Hippocampal slices from these mutant mice have multiple neuronal and astrocytic abnormalities of glucose metabolism, including reduced glucose oxidation, decreased phosphorylation of pyruvate dehydrogenase, and delayed replenishment of glycogen stores. Targeting mitochondrial superoxide production prevents excitotoxic injury and restores synaptic function. Excitotoxicity thus appears to be finely controlled by mitochondrial superoxide homeostasis tightly linked to the metabolic functions of neuronal GLT‐1. We have previously reported a failure of recovery of synaptic function in the CA1 region of acute hippocampal slices from mice with a conditional neuronal knockout (KO) of GLT‐1 (EAAT2, Slc1A2) driven by synapsin‐Cre (synGLT‐1 KO). The failure of recovery of synaptic function is due to excitotoxic injury. We hypothesized that changes in mitochondrial metabolism contribute to the heightened vulnerability to excitotoxicity in the synGLT‐1 KO mice. We found impaired flux of carbon from 13C‐glucose into the tricarboxylic acid cycle in synGLT‐1 KO cortical and hippocampal slices compared with wild‐type (WT) slices. In addition, we found downregulation of the neuronal glucose transporter GLUT3 in both genotypes. Flux of carbon from [1,2‐13C]acetate, thought to be astrocyte‐specific, was increased in the synGLT‐KO hippocampal slices but not cortical slices. Glycogen stores, predominantly localized to astrocytes, are rapidly depleted in slices after cutting, and are replenished during ex vivo incubation. In the synGLT‐1 KO, replenishment of glycogen stores during ex vivo incubation was compromised. These results suggest both neuronal and astrocytic metabolic perturbations in the synGLT‐1 KO slices. Supplementing incubation medium during recovery with 20 mM D‐glucose normalized glycogen replenishment but had no effect on recovery of synaptic function. In contrast, 20 mM non‐metabolizable L‐glucose substantially improved recovery of synaptic function, suggesting that D‐glucose metabolism contributes to the excitotoxic injury in the synGLT‐1 KO slices. L‐lactate substitution for D‐glucose did not promote recovery of synaptic function, implicating mitochondrial metabolism. Consistent with this hypothesis, phosphorylation of pyruvate dehydrogenase, which decreases enzyme activity, was increased in WT slices during the recovery period, but not in synGLT‐1 KO slices. Since metabolism of glucose by the mitochondrial electron transport chain is associated with superoxide production, we tested the effect of drugs that scavenge and prevent superoxide production. The superoxide dismutase/catalase mimic EUK‐134 conferred complete protection and full recovery of synaptic function. A site‐specific inhibitor of complex III superoxide production, S3QEL‐2, was also protective, but inhibitors of NADPH oxidase were not. In summary, we find that the failure of recovery of synaptic function in hippocampal slices from the synGLT‐1 KO mouse, previously shown to be due to excitotoxic injury, is caused by production of superoxide by mitochondrial metabolism.

Deficient brain GABA metabolism leads to widespread impairments of astrocyte and oligodendrocyte function

Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency

Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine

Depletion of Reduced Glutathione Enhances Motor Neuron Degeneration in Vitro and in Vivo

Proteome Alterations of Cortex and Hippocampus Tissues in Mice Subjected to Vitamin A Depletion

Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease

Glutamic acid decarboxylase 67 haplodeficiency in mice: consequences of postweaning social isolation on behavior and changes in brain neurochemical systems

Succinic semialdehyde dehydrogenase deficiency: review of the clinical phenotype and metabolic/genomic approach to diagnosis

Brain [U-13 C]glucose metabolism in mice with decreased α-ketoglutarate dehydrogenase complex activity

Metabolic Enzyme Alterations and Astrocyte Dysfunction in a Murine Model of Alexander Disease With Severe Reactive Gliosis

The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase

Metabolic modulation of synaptic failure and thalamocortical hypersynchronization with preserved consciousness in Glut1 deficiency

Autism spectrum disorder and GABA levels in children with succinic semialdehyde dehydrogenase deficiency

Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment

Metabolic reprogramming in astrocytes results in neuronal dysfunction in intellectual disability

Clinical diagnosis and mutation analysis of four Chinese families with succinic semialdehyde dehydrogenase deficiency

Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer's disease astrocytes

The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency

Misprogramming of glucose metabolism impairs recovery of hippocampal slices from neuronal GLT‐1 knockout mice and contributes to excitotoxic injury through mitochondrial superoxide production

Metabolic stroke: A novel presentation in a child with succinic semialdehyde dehydrogenase deficiency

Brain Microvasculature Defects and Glut1 Deficiency Syndrome Averted by Early Repletion of the Glucose Transporter-1 Protein